Location History:
- Woburn, MA (US) (2009 - 2020)
- Lexington, MA (US) (2020 - 2022)
Company Filing History:
9 out of 3,924 
1 out of 23 
1 out of 1 Years Active: 2009-2022
Title: Lei Shu: Innovating in Pharmaceutical Chemistry
Introduction
Lei Shu, based in Woburn, MA, is a distinguished inventor with a remarkable portfolio of 10 patents. His work primarily focuses on pharmaceutical chemistry and the development of innovative compounds aimed at treating various medical conditions. Shu’s contributions provide a significant impact within the field, particularly in addressing rare diseases related to spinal muscular atrophy.
Latest Patents
Among his latest patents, Shu has developed a groundbreaking compound related to 1,4-disubstituted pyridazine analogs that target SMN-deficiency-related conditions. The patent outlines a compound of formula I or a pharmaceutically acceptable salt thereof, detailing a method for manufacturing these compounds and their therapeutic applications. Furthermore, it presents a combination of pharmacologically active agents alongside a comprehensive pharmaceutical composition, showcasing his innovative approach to drug development.
Career Highlights
Throughout his career, Lei Shu has collaborated with prominent pharmaceutical companies, including Novartis AG and Vicuron Pharmaceuticals Inc. His work in these organizations has allowed him to advance his research while contributing to various cutting-edge projects in drug formulation and therapeutic applications.
Collaborations
In his professional journey, Shu has had the privilege of working alongside notable colleagues, including Natalie Alysia Dales and John Ryan Kerrigan. These collaborations have enriched his research endeavors, fostering an environment of shared knowledge and innovation within the pharmaceutical industry.
Conclusion
With his extensive experience and a strong focus on creating therapeutic solutions for complex medical challenges, Lei Shu stands out as a prominent figure in the realm of pharmaceutical inventions. His dedication to research and his substantial patent portfolio underscore his role as an innovator striving to improve health outcomes through scientific advancement.